BioCentury
ARTICLE | Company News

Atugen Biotechnology GmbH, Transgenic Berlin-Buch GmbH deal

February 1, 1999 8:00 AM UTC

Atugen acquired Transgenic Berlin-Buch, a drug discovery company specializing in transgenic rodent technology using DNA micro-injection (see BioCentury, Oct. 5, 1998). ...